Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Infections and Infectious Diseases | Hepatology (Liver, Pancreatic, Gall Bladder) | Gastroenterology | Immunology

Clinical Trials: Hepatitis B


A listing of clinical trials currently looking for volunteers to enroll in Hepatitis B studies. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Huntsville : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

California

Garden Grove : Sc Clinical Research, Inc.

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Los Angeles :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Los Angeles : Asian Pacific Liver Center

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Palo Alto : Stanford University

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List

Palo Alto : Stanford University Medical Center,750 Welch Road, Ste. 210

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

View More »

Sacramento : University Of California Davis Medical Center

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

San Diego : University of California Antiviral Research Center (AVRC)

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

San Diego : University of California Antiviral Research Center (AVRC)

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

San Diego : Research and Education Inc

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

San Francisco : University Of California, San Francisco

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

San Francisco :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

San Jose : San Jose Gastroenterology

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Connecticut

Hartford : Connecticut Children'S Medical Center

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

New Haven : Yale University School Of Medicine

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

District of Columbia

Washington : Children'S National Medical Center

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Washington : Georgetown University Hospital

Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

Florida

Gainesville : University Of Florida

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Maitland : Centre for Advanced Gastroenterology

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Miami : Clinical Pharmacology Of Miami Inc.

Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction

Miami : University of Miami / Jackson Memorial Medical Center

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Orlando : Orlando Clinical Research Center

Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction

Georgia

Atlanta : Romero, Rene

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Atlanta : Atlanta Gastroenterology Associates

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Atlanta :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Idaho

Meridian : Advanced Clinical Research, ID

Hepatitis B Vaccine Clinical Research Study

View More »

Boise : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Illinois

Chicago : University of Chicago

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Indiana

Indianapolis : Indiana University Medical Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Indianapolis : Indiana University Medical Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Inidanapolis : Indiana University School Of Medicine / Riley Hospital

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Mishawaka : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Kansas

Kansas city : University of Kansas Medical Center,3901 Rainbow Blvd, MS 1023

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Wichita : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Louisiana

New Orleans : Tulane University Health Sciences Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

New Orleans : Tulane University Health Sciences Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

New Orleans : LSU Gastroenterology/Center for Digestive Diseases

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Maryland

Baltimore : Johns Hopkins School Of Medicine

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Baltimore : Mercy Medical Center

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Baltimore : Digestive Disease Associates

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Bethesda : National Institute of Allergy and Infectious Diseases

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Bethesda : National Institute of Allergy and Infectious Diseases

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

View More »

Colombia : Gastro Center Of Maryland

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Massachusetts

Boston : Shah, Uzma

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Boston : Children'S Hospital Boston

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Boston : Beth Israel Deaconess Medical Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Boston :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Boston : BIDMC

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

View More »

Boston : Massachusetts General Hospital

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List

Boston : Boston Medical Center,85 E. Concord St

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Boston : Tufts Medical Center,800 Washington Street

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Michigan

Detroit : Henry Ford Health System

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Detroit : Henry Ford Health System

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Detroit : Henry Ford Health System

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Detroit : Henry Ford Hospital

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Minnesota

Minneapolis : University Of Minnesota

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Minneapolis :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Missouri

Kansas City : Kansas City Gastroenterology and Hepatology

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Kansas City : Kansas City Gastroenterology and Hepatology

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

St. Louis :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

St. Louis : Bruce Bacon M.D.

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

New Jersey

Hillsborough : ID Care, Inc.

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

New York

Manhasset : Biomedical Research Alliance of New York

Chronic Hepatitis B

New York : Clinilabs, Inc.

Do you have Hepatitis B?

View More »

Endwell : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Flushing : Office Of Sing Chan Md

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Flushing : Medical Procare, Pllc

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Flushing : 132-21 41 Ave. Suite 1A

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Great Neck : North Shore University Hospital

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

New York : Mount Sinai Medical Center

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

New York : CliniLabs

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

New York : Weill Cornell Medical College

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

New York : CliniLabs

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

New York : Weill Cornell Medical College

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

New York : New York School of Medicine

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

New York :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

New York : Beth Israel Medical Center

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

New York : New York Univ. Medical Center

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

New York : Weill Cornell Medical College of Cornell University, 1305 York Ave. 4th floor

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

New York : Mount Sinai Medical Center,One Gustave L. Levy Place, 1123

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

North Carolina

Charlotte : Levine Children'S Hospital At Carolinas Medical Center

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Durham : Duke University Medical Center

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

Wilmington : Registry Coordinating Center

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

Ohio

Cleveland : Rapid Medical Research, Inc. (RMR)

Hepatitis B Vaccine Clinical Research Study

View More »

Cleveland : University Hospitals Case Medical Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Cleveland : University Hospitals Case Medical Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Cleveland : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Cleveland : Case Western Reserve,11100 Euclid Avenue

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Oregon

Portland : Oregon Health Science University

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Pennsylvania

Philadelphia : Children'S Hospital Of Philadelphia

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Philadelphia : CRI Worldwide, LLC

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Philadelphia : 121 N. 9th Street

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Rhode Island

Providence : Rhode Island Hospital

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Tennessee

Nashville : Clinical Research Associates, Inc.

HEPATITIS B (HBV) VACCINE

Nashville : Clinical Research Associates, Inc.

Hepatitis B Vaccine for Type 2 Diabetics

View More »

Knoxville : New Orleans Center For Clinical Research - Knoxville

Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction

Nashville : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Texas

Houston : Baylor College of Medicine - St. Luke's Episcopal Hospital

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Houston : Texas Children'S Hospital

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Houston : Baylor College of Medicine

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Houston : Baylor College of Medicine

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Houston :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

View More »

Houston : Texas Children's Hospital

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Houston : Liver Associates of Texas,

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Houston : Advanced Liver Therapies at St. Luke's Episcopal Hospital

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Houston : Kelsey Research Foundation

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Utah

Salt Lake City : J. Lewis Research, Inc.

Research study of a Hepatitis B vaccine in adults 20 to 49 years of age, with or without Type 2 Diabetes

View More »

Salt Lake City : University of Utah

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Salt Lake City : University of Utah

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Salt Lake City : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Salt Lake City : University of Utah, 30 North 1900 East ,4R118 SOM

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Virginia

Fairfax : Inova Fairfax Hospital For Children

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Richmond : Liver Institute of Virginia, Bon Secours Health System

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Richmond : McGuire Research Institute

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Washington

Seattle :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Wenatchee : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Argentina

Bunos Aires : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Australia

Adelaide : Flinders Medical Center, 1 Flinders Drive,Bedford Park

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Adelaide SA : Royal Adelaide Hospital,Dept. of Gastroenterology and Hepatology, North Terrace

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Box Hill : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Camperdown : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Camperdown : Royal Prince Alfred Hospital,AW Morrow Gastroenterology and Liver Center, Level 9 E- Block

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

View More »

Clayton : Monash University, Department of Medicine

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Clayton : Monash University, Dept. of Medicine

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Clayton : Monash Medical Centre,Gastrointestinal and Liver Unit,246 Clayton Road

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Clayton Vic : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Concord : Concord Repatriation General Hospital,Department of Gastroenterology

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Fitzroy : Saint Vincents Hospital,Daly Wing 41 Victoria Parade

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Footscray : Western Hospital,Dept. of Medicine,Gordon Street

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Fremantle : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Fremantle : Fremantle Hospital,B2 Clinic, Alma Street,

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Heidelberg : Austin Health,Dept. of Hepatology,145-163 Studley Road

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Heidelberg Vic : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Herston : Royal Brisbane and Women's Hospital

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Herston : Royal Brisbane and Women's Hospital

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Herston : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Herston : Royal Brisbane & Women's Hospital,C5 Clinical Sciences Building,Butterfield Street

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Kogarah : Saint George's Hospital,Pitney Building, Second Floor,Belgrave Street

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Liverpool : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Liverpool : Liverpool Hospital,Gastroenterology Department,Cr Elizabeth and Goulburn Streets

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Melbourne : Alfred Hospital

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Melbourne : The Austin

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Melbourne : Alfred Hospital, Department of Gastroenterology

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Melbourne :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Melbourne : The Alfred Hospital

A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

Melbourne : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Melbourne : The Alfred Hospital

HIV-HBV Co-Infection and Liver Disease

Melbourne : Alfred Hospital,Commercial Road/ Level 4 Main Ward Block

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Melbourne : Box Hill Hospital,Eastern Health,Level 2,5 Arnold Street,Box Hill

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Nedlands : Royal Perth Hospital

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Nedlands : Royal Perth Hospital

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Nedlands : Sir Charles Gairdner Hospital,Dept. of Gastroenterology Hepatology,6th Floor G Block

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

North Adelaide :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Parkville : Royal Melbourne Hospital,Victorian Inf. Diseases Services,Grattan Street

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Perth : Linear Clinical Research Ltd

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Perth : Royal Perth Hospital,Wellington Street

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.

A Study of the Safety and Efficacy of PEG-Intron™ Versus PEGASYS™ in Participants With Chronic Hepatitis B (P08450 AM1)

St Albans : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Westmead : Storr Liver Unit- Westmead Hospital,Hawkesbury Road

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Westmead Nsw : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Woolloongabba : Princess Alexandra Hospital,Dept of Gastroenterology and Hepatology,Level 4 Building 1 199 Ipswich Road

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Belgium

Brussels :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Gent :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Bulgaria

Pleven :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Plovdiv :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Sofia :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Sofia : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Stara Zagora :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

View More »

Varna :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Varna : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Canada

Calgary : University of Calgary, Heritage Medical Research Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Calgary : University of Calgary, Heritage Medical Research Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Calgary : Heritage Med Research Clinic, Univ of Calgary

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Edmonton : Nottingham University Hospitals NHS Trust

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Edmonton : University of Alberta Hospital

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

View More »

Edmonton : University of Alberta Hospital

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Laval : Algorithme Pharma, Inc.

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Montreal : Algorithme Pharma

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Montreal : Algorithme Pharma, Inc.

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Montreal :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Ottawa : The Ottawa Hospital, General Campus

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Ottawa : The Ottawa Hospital,Division of Infectious Diseases,G12-501 Smyth Road

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Quebec City : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

St. Romuald : Pro-recherche

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Ste-Foy : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Sudbury : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Toronto : Toronto General Hospital

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Toronto : Toronto Liver Centre

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Truro : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Vancouver : Downtown Infectious Diseases Clinic - University of British Columbia

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Vancouver : Gastrointestional Research Institute

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Vancouver : Gordon & Leslie Diamond Health Care Centre

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Vancouver : Liver and Intestinal Research Centre

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Zeidler Ledcore Centre : University of Alberta,Zeidler Ledcore Centre

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

China

Beijing : National Center for AIDS/STD Control and Prevention, China CDC

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

Beijing : Beijing Ditan Hospita

EFFORT Extension Study

Beijing : Beijing Friendship Hospital Attached To The Capital Medical University

EFFORT Extension Study

Beijing : Department of Infectious Disease, First Hospital of Peking University

EFFORT Extension Study

Beijing : 302 Military Hospital Of China

EFFORT Extension Study

View More »

Beijing : BeiJing YouAn Hospital ,Capital Medical University

EFFORT Extension Study

Beijing : People's Hospital Under Beijnig University

EFFORT Extension Study

Chang Chun : Hepatobiliary Disease Hospital of Jilin Province

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Changchun : First Hospital .Jilin Unniversity

EFFORT Extension Study

Changsha : Xiangya Hospital Central-South Univrsity

EFFORT Extension Study

Chengdu : West China Hospital.SiChuan University

EFFORT Extension Study

Chongqing :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Chongqing : The Second Affiliated of ChongQing University of Medical Science

EFFORT Extension Study

Chongqing : Southwest Hospital

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Guangzhou : Department of Infectious Disease, Nanfang Hospital

EFFORT Extension Study

Guangzhou : No. 8 People's Hospital In GuangZhou

EFFORT Extension Study

Guangzhou : The Third Hospital of Sun Yat-Sen University

EFFORT Extension Study

Hangzhou : The First Affiliated Hospital of College of Medicine, Zhejiang University

EFFORT Extension Study

Hangzhou : The Sixth People's Hospital of Hangzhou

EFFORT Extension Study

Hong Kong : Department of Medicine, Queen Mary Hospital

Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB

Jinan : JiNan Infectious Diseases Hospital

EFFORT Extension Study

Nan Jing : The Second Affiliated Hospital of the Southeast University

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Nanjing : No.81 Hospital of PLA

EFFORT Extension Study

Nanyang : Nanyang Central Hospital

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Shanghai : No.85 Hospital of PLA

EFFORT Extension Study

Shanghai : Changhai Hospital affiliated to Second Military Medical University

EFFORT Extension Study

Shanghai : Huashan Hospital,Fudan University

EFFORT Extension Study

Shanghai : Shanghai Ruijin Hospital

EFFORT Extension Study

Shengyang : ShengJing Hospital of China Medical University

EFFORT Extension Study

Shijiazhuang : The Fifth Hospital of Shijiazhuang

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Wuhan : Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology

EFFORT Extension Study

Xian : Tangdu Hospital

EFFORT Extension Study

France

Clichy : Service Hepatologie- Centre Pierre Abrami

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Clichy Cedex : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Lyon : Hôpital de la Croix Rousse, Service Hepatogastro enterologie-endoscopie

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Marseille : Hôpital Saint Joseph, Service d'hépatogastroentérologie

A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B

Nice Cedex 03 : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

View More »

Paris : Hopital Tenon- 4 Rue de la Chine

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Paris : Hopital Cochin CIC de vaccinologie

Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients

Paris Cedex 12 : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Rennes Cedex 9 : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Rennes, 35 : CHU de Rennes,2 rue Henri Le Guilloux

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Rouen : Hopital Charles Nicolle

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Strasbourg : Centre Hospitalier Regional et Universitaire de Strasbourg, Hopital Civil

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Toulouse : Centre Hospitalier Universitaire Purpan

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Villejuif Cedex : Hopital Paul Brousse

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Germany

Berlin : Leberzentrum am Checkpoint

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Berlin : Private Practice

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Berlin : Charite CVK

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Berlin : Charite Berlin, Campus Virchow-Klinikum- Augustenburger Platz 1

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Bonn : Universitaetsklinikum Bonn

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

View More »

Duesseldorf : Zentrum für HIV und Hepatitis

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Essen : Universitätsklinikum Essen - klinikum für Gastroenterolgie und Hepatologie,

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Essen : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Frankfurt : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Frankfurt : J.W. Goethe Universitaetsklinikum

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Frankfurt : Johann-Wolfgang-Goethe Universitat,

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Freiburg : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Halle : Martin-Luther University Halle-Wittenberg

Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on Hemodialysis

Hamburg : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Hamburg : ifi Studien und Projekte GmbH

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Hamburg : Universitaetsklinikum Hamburg Eppendorf

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Hamburg : Asklepios Westklinikum

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Hamburg : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Hannover : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Hannover : Medizinische Hochschule Hannover

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Hannover : Medizinische Hochschule Hannover,Hastroenterologie und Hepatologie

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Heidelberg : Universitaetsklinik Heidelberg

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Herne : Gastroenterologische Gemeinschaftspraxis

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Herne : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Kiel : Gastroenterologische Gemeinschaftspraxis

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Köln : Universitatsklinik Koln

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Leipzig :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Leipzig : Universitaetsklinikum Leipzig

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Leipzig : Universitatsklinikum Leipzig

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Leipzig : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Leverkusen : Gemeinschaftspraxis Gastroenterologie

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Mainz : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Mainz : Universitätsmedizin Mainz, I. Med. Klinik und Poliklinik

Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen

Mainz : Universitaetsklinikum Mainz

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Mainz : Johannes Gutenberg-Universitat Mainz,

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Muenchen : Klinikum der LMU Grosshadern

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Muenster : Centrum interdisziplinaere Medizin

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Starnberg : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Tuebingen : Universitaetsklinik Tuebingen

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Ulm : Universitaetsklinikum Ulm

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Wuppertal : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Wuppertal :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Greece

Athens : Athens Univ Med School,Int Med 2nd,Vas Sofias Street 114

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Patra : University Hospital of Patras,Department of Internal Medicine,Rio, Patra

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Thesaloniki : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Thessaloniki : Hippokration Hospital of Thessalonica,49 Konstantinoupoleous Str.

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Hong Kong

Hong Kong : University of Hong Kong ,Queen Mary Hospital,102 Pokfulan Road

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Kowloon : Princess Margaret Hospital,2-10 Princess Margaret Hosp Rd

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Pokfulam : Queen Mary Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Shatin : Prince of Wales Hospital, 9/F,

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Tai Po : Alice Ho Miu Ling Nethersole Hospital, 11 Chuen On Road

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

India

Chandigarh : School of Public Health, Post Graduate Institute of Medical Education and Research

Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

Coimbatore : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Guwahati : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Hyderabad : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Vijaywada : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Israel

Beer-Sheva : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Haifa : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Haifa :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Jerusalem :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Zefat :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Italy

Bologna :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Firenze : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Milano :

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Milano : Fondazione Centro San Raffaele del Monte Tabor

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Milano : Fondazione IRCCS Ca Granda - Ospedale Maggiore Policlinico,via Francesco Sforza 28/35

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

View More »

Modena : A.O.U. Policlinico Università di Modena e Reggio Emilia

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Napoli : Seconda Universita degli Studi di Napoli,via Cotugno 1

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Padova : Az. Ospedaliera Universitaria di Padova

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Pisa :

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Pisa : Azienda Ospedaliero Universitaria Pisana

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Roma : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Roma : Fondazione PTV - Policlinico Tor Vergata,via Montpellier 1

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Rome : Policlinico Umberto I, Dipartimento di Malattie Infettive e Tropicali,v.le del Policlinico 155

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Torino :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Torino : Az. Ospedaliera S.Giovanni Battista di Torino

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Korea, Republic of

Ansan-si : Korea University Ansan Hospital,516, Gojan 1-dong,516, Gojan 1-dong

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Bucheon : Soon Chun Hyang University Bucheon Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Bucheon : Bucheon St. Mary''s Hospital,2 Sosa-dong, Wonmi-gu

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Busan : Inje University Haeundae Paik Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Busan : Dong-A University Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

View More »

Busan : Kosin University Gospel Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Busan : Pusan National University Hospital,305 Gudeok-Ro

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Cheonan : Dankook University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Cheonan : SoonChunHyang University Hospital Cheonan,23-20, Byeongmyeong-dong,

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Chuncheon : Chuncheon Sacred Heart Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Daegu : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Daegu : Kyungpook National University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Daegu : Yeungnam University Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Daegu : Kyungpook National University Hospital,130 Dongduk-ro

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Goyang : Inje University Ilsan Paik Hospital,2240, Daewha-dong,Ilsan seo-Gu

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Guri : Hanyang University Guri Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Jeju : Jeju National University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Kwangjin-gu, Seoul : Digestive Disease Cntr, Konkuk Univ Hosp,4-12 Hwayang-dong

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Seocho-gu, Seoul : Seoul Saint Mary''s Hospital,505 Banpo-dong

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Seongnam : SKChemicals

A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients

Seoul : Hanyang University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Inje University Sanggye Paik Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kangbuk Samsung Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kangdong Sacred Heart Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kangnam Severance Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Konkuk University Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kyunghee university Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Shinchon Severance Hospital

HBsAg Related Response Guided Therapy

Seoul : Department of clinical pharmacology and therapeutics

Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection

Seoul : Seoul National University Hospital,101 Daehak-ro,Jongno-Gu

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Seoul : Severance Hospital,Yonsei University Health System,250 Seongsanno Seodaemun-gu

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Seoul : Asan Medical Center,388-1 Pungnap-2-Dong

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Seoul : Gangnam Severance Hospital,146-92 Dogok-Dong,Kangnam-gu

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Seoul : Korea University Guro Hospital,80, Guro 2-dong,Guro-Gu

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Sungnam : Bundang CHA medical center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Sungnam : CHA Bundang Medical Center, CHA University,351, Yatap-dong,Bundang-gu

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Uijeongbu : Uijeongbu St.Mary's Hospital

A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

Wonju : Wonju Christian Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Wonju : Yonsei Unversity Wonju College of Medicine Wonju Christian Hospital,162 ilsan-dong

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Yangsan : Busan National University Yangsan Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Yangsan : Pusan National University Yangsan Hospital,Beomeo-ri, Mulgeum-eup

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Yangsan-si : Pusan National University Yangsan Hospital

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Netherlands

Amsterdam : Vrije Universiteit Medisch Centrum,De Boelelaan 1117

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Amsterdam : Academisch Medisch Centrum

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Rotterdam : Erasmus Medical Center

PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients

Rotterdam : Erasmus MC,Afdeling Gastroenterologie,S Gravendijkwal, 230

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

New Zealand

Grafton : Auckland Clinical Studies

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Grafton : Auckland Clinical Studies

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Grafton : Aukland Clinical Studies

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Hamilton : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Rotorua : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

View More »

Takapuna Auckland : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Wellington : GSK Investigational Site

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Poland

Bialystok : Wojewodzki Szpital Specjalistyczny im Dluskeigo, ul Zurawia 14

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Bydgoszcz : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Bydgoszcz :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Bydgoszcz : Collegium Medicum Uniwersytet im. Mikołaja Kopernika

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Bydgoszcz : Klinika Chorob Zakaznych AM,Szpital Obserwacyno-Zakazny im.T.Browicza,ul. Sw. Floriana 12 Str.

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

View More »

Chorzów : Szpital Specjalistyczny w Chorzowie,Oddzial Obserwacyjno-Zakazny Hepatologii Zakaznej i Nabytych Niedoborów Odpornosci Klinicznej,ulica Zjednoczenia 10

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Krakow : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Krakow :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Krakow : Szpital Uniwersytecki w Krakowie,Klinika Chorob Zakaznych I Hepatologii,ul.Sniadeckich 5

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Lodz : Oddziak Obserwacyjno-Zakazny, ul. Kniaziewicza 1/5,Klinika Obserwacyjno - Zakazna

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Lodz : Wojewódzki Specjalistyczny Szpital im. Dr Wladyslawa Bieganskiego w Lodzi,ulica Kniaziewicza 1/5

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Lublin : Samodzielny Publiczny Szpital Kliniczny 1,Klinika Chorób Zakaznych,ulica Staszica 16

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Poznan :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Szczecin : Samodzielny Publiczny Wojewódzki Szpital Zespolony

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Warsaw : Wojewódzki Szpital Zakaźny

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Warszawa : SP ZOZ Wojewodzki Szpital Zakazny w Warszawie,ul. Wolska 37

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Wroclaw : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Wrocław : NZOZ Centrum Badan Klinicznych

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Portugal

Lisboa : Hospital de Egas Moniz,Rua da Junqueira, 126

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Lisboa : Hospital de Santa Maria

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Porto : Hospital São João, Alameda Professor Hernâni Monteiro

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Porto : Centro Hospitalar do Porto,Serviço de Gastrenterologia,Largo Prof. Abel Salazar

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Romania

Bucharest : National Institute of Infectious Diseases

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Bucharest : Fundeni Clinical Institute

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Bucharest : Grigore Alexandrescu Emergency Clinical Hospital for Children

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Bucharest : Institutul National de Boli Infectioase "Prof. Dr. Matei Bals"

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Bucharest : Spitalul Clinic de Boli Infectioase "Dr. Victor Babes"

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

View More »

Bucharest : Institutul National de Boli Infectioase Prof.Dr. Matei Bals

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Bucuresti : Colentina Clinical Hospital

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Criova : "Victor Babes" Clinical Hospital of Infectious Diseases and Pneumophtisology

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Iasi : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Sibiu : Spitalul Clinic Judetean Sibiu

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Russian Federation

Moscow : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Moscow :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Novokuznetsk : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

Saint Petersburg :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Samara :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

View More »

Samara :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

St Petersburg :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Stavropol :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Singapore

Singapore : Tan Tock Seng Hospital,11 Jalan Tan Tock Seng

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Singapore : Singapore General Hospital,Ntnl Univ Hosp, Dept of Gastroenterology,Outram Road

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Singapore : National University Hospital Singapore,Div of Gastroenterology and Hepatology,1E Kent Ridge Road, Dept of Med

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Singapore : Changi General Hospital,Division of Gastroenterology,Depart of Medicine, 2 Simei Street 3

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Spain

Barcelona : Hospital General Universitari Vall d' Hebron

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Barcelona : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

El Palmar : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Madrid : Hospital Universitario La Princesa

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Madrid : Hospital Carlos III, Digestive Department, Sinesio Delgado 10

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

View More »

Sevilla : Hospital Virgen de la Victoria

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Sevilla : Hospital Universitario Virgen del Rocio

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Vigo, Pontevedra : Hospital Meixoeiro,Meixoeiro, S/N

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Taiwan

Changhua, : Changhua Christain Hospital,No.135 Nanhsiao Street

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Chia-Yi : Chiayi Christian Hosp,Div. of Hepato-Gastro,No.539 ,Jhongsiao Rd

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Chia-Yi : Chia-Yi Christine Hospital

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Hualien : Buddhist Tzu Chi General Hospital,Div. of Hepato-Gastroenterology,No. 707, Sec. 3, Chung Yang Rd.

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Kaohsiung : Chang Gung Memorial Hospital,3F Liver Unit,123 Ta- Pei Rd Niao-Sung Hsiang

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

View More »

Kaohsiung : E-Da Hospital

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Kaosiung : Kaohsiung Medical University Hospital,Hepatobiliary Division,100 Shih-Chuan 1st Rd.

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Keelung Town/KEELUNG CITY : Chang Gung Medical Foundation-Keelung,Chang Gung Med FDN -Keelung,No.222, Mai-Chin Road

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

New Taipei City : Far-Eastern Memorial Hosp,Div.of Hepato-Gastro,No.21, Sec. 2, Nanya S. Rd.,

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Taichung : Chung Shan Medical University Hospital,,Div. of Hepato-Gastro,Number 110, Section 1, Chien-Kuo North Road

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Taichung : Taichung Veterans Genl Hosp,No. 160, Sec. 3, Chung-Kang Rd

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Taichung : China Medical University Hospital

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Taichung : Taichung Veterans General Hospital

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Tainan : National Cheng Kung University Hospital,Clin Pharm Outpatient Bldg 1F

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Taipei : National Taiwan University Hospital Department of Internal medicine

Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B

Taipei : Department of Internal Medicine

Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C

Taipei : Taipei Veterans General Hospital-Division of Gastroenterology, Division of Oncology

Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B

Taipei : Cathay General Hospital,280 Jen-Ai Road, Sec. 4

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Taipei : National Taiwan University Hospital,

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Taoyuan : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Tao-Yuan : Chang Gung Memorial Hospital - Linkou,Chang Gung Univ Coll of Medicine,Number 5, Fu-Hsing Street

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Yunlin County : National Taiwan University Hospital Yun-Lin Branch

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Thailand

Bangkok :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Chiang Mai :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Khon Kaen :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Songkhla :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Turkey

Ankara : Hacettepe Üniversitesi Tip Fakültesi

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Dikimevi : Ankara Üniversitesi Tip Fakültesi Gastroenteroloji Bilim Dali

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Gaziantep : Gaziantep Univ. Med. Faculty

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Istanbul : Istanbul Universitesi Istanbul Tip Fakultesi

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Mersin : Istanbul Universitesi Cerrahpassa Tip Fakultesi Hastanesi,Gastroenteroloji Bilim Pali

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

United Kingdom

Birmingham : University Hospitals Birmingham NHS Foundation Trust

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Birmingham :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Birmingham, WSTMID : Queen Elizabeth Hospital,

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Hampstead,London : Royal Free Hospital

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

London : Barts & The London NHS Trust - Queen Elizabeth Hospital

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

View More »

London : Institute of Liver Studies, King's College Hospital

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

London : Local Institution

A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection

London :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

London : King's College Hospital,Institute of Liver Studies

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

London : Barts & The London NHS Trust,Centre For Gastroenterology

Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).

Nottingham : Nottingham University Hospitals NHS Trust

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B